@hormonedoctor's TRT side effects advice, fact-checked

What did @hormonedoctor actually say?

The claim here is specific: men on testosterone replacement therapy often feel great for the first six weeks, then crash around two to three months in. The doctor pins this on SHBG, sex hormone binding globulin, getting suppressed so aggressively by androgens that the liver slows its production of the protein. The result, in their framing, is that free testosterone swings too high, triggering mood swings, fatigue, and even erectile dysfunction. Their prescription? You need someone tracking SHBG and free testosterone, not just total T.

The setup is a familiar one for men in TRT communities, and the creator is speaking to a real phenomenon that gets dismissed in a lot of primary care offices. Credit where it's due: the frustration described, "you're pretty much talking to a brick wall," is something a lot of patients report. But the mechanistic explanation they offer is where things get complicated.

Does the science back this up?

Partially, yes. SHBG does decline with androgen exposure, and this is well-documented. But the causal chain the creator builds, where SHBG crashes, free T overshoots, and that overshoot causes the symptom relapse, is oversimplified to the point of being misleading in some respects.

A 2019 study by Ramasamy et al. in The Journal of Urology confirmed that exogenous testosterone suppresses SHBG, which does affect free testosterone calculations. However, the relationship between calculated free T, actual bioavailable testosterone at the tissue level, and subjective wellbeing is not linear or consistent across men. A 2021 review by Handelsman in Endocrine Reviews specifically cautioned against over-relying on free testosterone calculations as clinical decision-making tools, noting significant variability across lab assays.

The claim that androgen-driven SHBG suppression causes free T to become "too high" and that this directly produces mood swings and erectile dysfunction is not well-supported by clinical trial data. Estradiol elevation from aromatization, injection frequency, and individual receptor sensitivity are more commonly cited drivers of those symptoms in the literature.

What did they get wrong (or right)?

They got the SHBG suppression mechanism directionally correct. Testosterone does reduce hepatic SHBG synthesis. That part is real. And they are right that many clinicians only check total testosterone and miss the bigger picture.

But the creator seriously oversimplifies the "free T too high causes the crash" argument. Symptom relapse on TRT at two to three months is a recognized clinical pattern, but the causes are multifactorial. Elevated estradiol from aromatization is a more frequently documented culprit than SHBG suppression alone. A 2016 study by Ramasamy et al. in Fertility and Sterility noted that estradiol management, not just free T or SHBG tracking, was a key variable in symptom resolution for men on TRT.

The 200 mg every-two-weeks dosing criticism is actually fair. That protocol produces wide peaks and troughs and is increasingly considered suboptimal by most endocrinology and urology guidelines. The Endocrine Society's 2018 clinical practice guidelines recommend against large infrequent doses for exactly this reason. The creator earns points there.

What they do not earn points for: this video ends with a sales pitch for a consultation. The mechanistic explanation, however partially accurate, is structured to make you distrust your current doctor and trust them instead. That framing deserves skepticism.

What should you actually know?

If you are on TRT and feel worse after the initial honeymoon period, you are not imagining it and your labs may genuinely be missing something. But the story is more complex than SHBG alone.

Clinicians experienced in TRT typically monitor total testosterone, free testosterone, estradiol, SHBG, hematocrit, PSA, and sometimes LH and FSH depending on fertility goals. Injection frequency matters too: splitting a weekly dose into twice-weekly injections tends to smooth out the peaks and troughs that drive symptom variability, per the 2018 Endocrine Society guidelines.

SHBG tracking is genuinely useful, particularly for men with naturally low or high baseline SHBG, which affects how they process testosterone. But treating SHBG suppression as the single explanation for TRT symptom relapse is too narrow. Estradiol, hematocrit changes, sleep disruption, and even the psychological letdown after the initial surge all play roles.

If your provider is dismissing your symptoms while pointing at in-range labs, it is reasonable to seek a second opinion from a urologist or endocrinologist with TRT experience. Just make sure whoever you consult is running a complete panel, not selling you a simplified narrative.